# BCG for Therapeutic Use Phase I Clinical Trial

> **NCT06100653** · PHASE1 · COMPLETED · sponsor: **Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.** · enrollment: 10 (actual)

## Conditions studied

- Non-muscular Invasive Bladder Cancer

## Interventions

- **DRUG:** BCG for therapeutic use

## Key facts

- **NCT ID:** NCT06100653
- **Lead sponsor:** Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-22
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-04-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06100653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06100653, "BCG for Therapeutic Use Phase I Clinical Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06100653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*